Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ACSM3 suppresses proliferation and induces apoptosis and cell cycle arrest in acute myeloid leukemia cells via the regulation of IGF2BP2. | Exp Ther Med | 2023 | 37006876 | PubTator, text mining | PubMed |
| Expression patterns of eight RNA-modified regulators correlating with immune infiltrates during the progression of osteoarthritis. | Front Immunol | 2023 | 37006267 | PubTator, text mining | PubMed |
| TGF-β signaling promotes cervical cancer metastasis via CDR1as. | Mol Cancer | 2023 | 37004067 | PubTator, text mining | PubMed |
| High-Throughput Sequencing Reveals That Rotundine Inhibits Colorectal Cancer by Regulating Prognosis-Related Genes. | J Pers Med | 2023 | 36983731 | PubTator, text mining | PubMed |
| FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m6A Modification and Necroptosis. | Genes (Basel) | 2023 | 36981005 | PubTator, text mining | PubMed |
| The Pleiotropic Ubiquitin-Specific Peptidase 16 and Its Many Substrates. | Cells | 2023 | 36980227 | PubTator, text mining | PubMed |
| IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway. | Immunopharmacol Immunotoxicol | 2023 | 36972188 | PubTator, text mining | PubMed |
| The function and mechanisms of action of circular RNAs in Urologic Cancer. | Mol Cancer | 2023 | 36966306 | PubTator, text mining | PubMed |
| METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS. | Oncol Rep | 2023 | 36960869 | PubTator, text mining | PubMed |
| Roles and therapeutic implications of m6A modification in cancer immunotherapy. | Front Immunol | 2023 | 36960074 | PubTator, text mining | PubMed |
| m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway. | Cancer Lett | 2023 | 36958694 | PubTator, text mining | PubMed |
| Epigenetic control of mesenchymal stem cells orchestrates bone regeneration. | Front Endocrinol (Lausanne) | 2023 | 36950693 | PubTator, text mining | PubMed |
| Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders. | Cell Genom | 2023 | 36950384 | PubTator, text mining | PubMed |
| Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells. | Adv Sci (Weinh) | 2023 | 36949364 | PubTator, text mining | PubMed |
| NR1H4-mediated circRHOBTB3 modulates the proliferation, metastasis, and Warburg effects of cervical cancer through interacting with IGF2BP3. | Mol Cell Biochem | 2023 | 36939994 | PubTator, text mining | PubMed |
| The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response. | Cancer Res | 2023 | 36939388 | PubTator, text mining | PubMed |
| Emerging trends and research foci of berberine on tumor from 2002 to 2021: A bibliometric article of the literature from WoSCC. | Front Pharmacol | 2023 | 36937842 | PubTator, text mining | PubMed |
| Association of circulating tumor cells and IMP3 expression with metastasis of osteosarcoma. | Front Oncol | 2023 | 36937398 | PubTator, text mining | PubMed |
| Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. | Mol Cancer | 2023 | 36932387 | PubTator, text mining | PubMed |
| RNA binding proteins are potential novel biomarkers of egg quality in yellow catfish. | BMC Genomics | 2023 | 36927412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=39